ARVN earnings: real EPS beat/miss history, analyst consensus Buy, P/E -2.53. Updated 2026-07-23.
Arvinas (ARVN) Research Hub
Arvinas (ARVN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 8.45 USD (-3.54%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.53, market cap 0.53B. This hub links to the full technical, earnings and options research available for ARVN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.45 USD (-3.54%) |
| 52-week range | 7.38 USD – 9.74 USD |
| Trend regime | Range |
| 14-day RSI | 45.1 (Neutral) |
| Trailing P/E | -2.53 |
| Market cap | 0.53B |
| Dividend yield | 0.00% |
Available research for ARVN
Covered Call on ARVN: how it works, illustrative setup around the real 8.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARVN: how it works, illustrative setup around the real 8.45 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARVN: how it works, illustrative setup around the real 8.45 USD price, max profit/loss, breakeven and when to use it. Educational.
ARVN technical analysis: range, last 8.45 USD, RSI 45.1, 52w range 7.38 USD–9.74 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ARVN in?
Arvinas (ARVN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ARVN in an uptrend or downtrend?
As of 2026-09-11, ARVN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARVN's trailing P/E ratio?
ARVN's trailing P/E is -2.53, with a market cap of 0.53B. See the earnings research page for full valuation detail.